Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 60760-698 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

698-60 - DIVALPROEX 60760 698 60

698-60 - DIVALPROEX 60760 698 60

This text provides information about a medication called Divalproex Sodium in tablet form. The tablets are delayed-release and contain 250mg of the active ingredient Valproic Acid. The prescription comes in a quantity of 60 tablets and carries the National Drug Code (NDC) number 60760-698-60. The medication is managed by Rising Health, LLC, located in Brunswick, NJ. It should be stored at room temperature between 15°C to 30°C (59°F-86°F) and used as directed.*

Figure 1 - divalproex fig1

Figure 1 - divalproex fig1

This text presents data from two studies comparing a placebo (PBO) with divalproex sodium delayed-release tablets (DVPX). The abbreviation "P80" is mentioned in reference to one of the studies. Additionally, there is a note indicating that statistical significance was reached with a p-value of less than 0.05.*

Figure 2 - divalproex fig2

Figure 2 - divalproex fig2

This is a chart showing the percentage of patients who experienced improvement, no change, or worsening of condition when treated with Divalproex Sodium Delayed-Release Tablets compared to placebo in CPS rats.*

Figure 3 - divalproex fig3

Figure 3 - divalproex fig3

This text shows a figure illustrating the percentage reduction in CPS rate, categorizing patients into high dose, low dose, improvement, no change, and worsening.*

Figure 4 - divalproex fig4

Figure 4 - divalproex fig4

This text provides information on the mean 4-week migraine rates in two studies comparing Placebo and Divalproex Sodium delayed-release tablets. It includes details on the mean dose of Divalproex Sodium delayed-release tablets used in the studies (1,087 mg/day) and the dosage range (500 or 1,000 mg/day) in Study 1 and Study 2.*

Chemical Structure - divalproex str

Chemical Structure - divalproex str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.